Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Core Scientific (CORZ) Long-Term Investments (2021)

Core Scientific has reported Long-Term Investments over the past 1 years, most recently at $345.0 million for Q4 2021.

Quarterly results put Long-Term Investments at $345.0 million for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $345.0 million (changed N/A YoY), and the annual figure for FY2021 was $345.0 million, changed.
Long-Term Investments reached $345.0 million in Q4 2021 per CORZ's latest filing, roughly flat from $345.0 million in the prior quarter.
Across five years, Long-Term Investments topped out at $345.0 million in Q4 2021 and bottomed at $345.0 million in Q1 2021.